Technology News and Research

RSS

Henry Ford Health System introduces 'Pill Timer' for medication management

A leader in healthcare, Henry Ford Health System will introduce at its hospitals and pharmacies "The Pill Timer," representing a "breakthrough" designed to improve treatment outcomes and reduce adverse drug events often resulting in costly hospital admissions due to poor medication management by patients.

26 Aug 2010

Panasonic introduces digital hearing instruments in U.S. market

Panasonic Corporation of North America, today announced that Panasonic Hearing instruments have been delivered to the U.S. market. The company is debuting three types of digital hearing instruments, including a new form factor that resembles the style of an MP3 player, a receiver-in-canal and behind-the-ear models. Panasonic is currently establishing a distribution network throughout the U.S.

From PHC Europe B.V. 26 Aug 2010

College students prevent female friends from engaging in risky sexual behavior after drinking alcohol

College students are less likely to let their female friends engage in risky sexual behavior after a night of drinking alcohol. Recent findings in the journal Communication Education examine how and why college students protect their friends who have been heavily drinking.

26 Aug 2010

Specific type of neurons determine frightening stimulus reaction: Research

Fear can make you run, it can make you fight, and it can glue you to the spot. Scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy and GlaxoSmithKline in Verona, Italy, have identified not only the part of the brain but the specific type of neurons that determine how mice react to a frightening stimulus.

26 Aug 2010

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.

26 Aug 2010

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Researchers from North Carolina State University have developed extremely small microneedles that can be used to deliver medically-relevant nanoscale dyes called quantum dots into skin - an advance that opens the door to new techniques for diagnosing and treating a variety of medical conditions, including skin cancer.

26 Aug 2010

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.

26 Aug 2010

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.

26 Aug 2010

Lockheed Martin awarded contracts to accelerate advancement of Nationwide Health Information Network

Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.

26 Aug 2010

Developing specific liver cell lines from stem cells holds promise for new liver disease treatment: Researchers

By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.

26 Aug 2010

FibroGen announces study results of recombinant human type III collagen in corneal damage

FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.

26 Aug 2010

TRT receives patent rights for procedure of reattaching damaged soft tissue to bone

Tissue Regeneration Technologies, LLC (TRT), a Woodstock, Georgia medical technology company, recently received the rights to a new patent to bolster its SoftWave technology portfolio. The patent covers a method of reattaching damaged soft tissue to bone.

26 Aug 2010

VCPI announces opening of 'The Center of Excellence for Post-Acute Care EMR'

VCPI announces the grand opening of The Center of Excellence for Post-Acute Care EMR today at the 4th Annual Client Connections Conference. The Center's team of experts will help providers of post-acute care accelerate the journey towards Electronic Health Records (EHR) to prepare for the competitive demands of the fully-digital, post-acute care world of 2014.

26 Aug 2010

Sysmex announces 3-year sole source microscopic urinalysis contract agreement with Novation

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.

From Sysmex America, Inc. 26 Aug 2010

Salinas Valley Memorial participates in trial of AngelMed Guardian System in high-risk heart patients

Imagine a day when you could be alerted to your impending heart attack before it happens. Research that got underway today at Salinas Valley Memorial Healthcare System could help that become a reality someday.

26 Aug 2010

Cornerstone Healthcare Plus REIT acquires $14.75M inpatient rehabilitation facility in Dallas

Cornerstone Real Estate Funds, and its strategic alliance partner and sub-advisor Servant Healthcare Investments, announced that the Cornerstone Healthcare Plus REIT has acquired an inpatient rehabilitation facility (IRF) for a purchase price of $14,750,000. The 42-bed, 40,000 square foot property is located in Dallas, Texas and is leased under a long-term lease to GlobalRehab LP.

26 Aug 2010

Ambry Genetics acquires Illumina HiSeq 2000 Sequencing and BeadXpress Genotyping systems

Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been an early adapter of Illumina systems since late 2007 and has extensive experience as a Certified Service Provider.

26 Aug 2010

Stryker Corporation announces definitive agreement to acquire Gaymar Industries

Stryker Corporation announced today a definitive agreement to acquire privately held Gaymar Industries. Under the terms of the agreement, Stryker will acquire Gaymar Industries for approximately $150 million in an all-cash transaction.

From Stryker 26 Aug 2010

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.

26 Aug 2010

IMA receives five-year renewal grant from National Science Foundation

The University of Minnesota's Institute for Mathematics and its Applications (IMA) has been awarded a $20.5-million National Science Foundation (NSF) renewal grant over the next five years. The renewal grant continues the IMA's tradition as one of the nation's top math institutes in terms of funding.

26 Aug 2010

Technology News and Research

Henry Ford Health System introduces 'Pill Timer' for medication management

Panasonic introduces digital hearing instruments in U.S. market

College students prevent female friends from engaging in risky sexual behavior after drinking alcohol

Specific type of neurons determine frightening stimulus reaction: Research

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

Lockheed Martin awarded contracts to accelerate advancement of Nationwide Health Information Network

Developing specific liver cell lines from stem cells holds promise for new liver disease treatment: Researchers

FibroGen announces study results of recombinant human type III collagen in corneal damage

TRT receives patent rights for procedure of reattaching damaged soft tissue to bone

VCPI announces opening of 'The Center of Excellence for Post-Acute Care EMR'

Sysmex announces 3-year sole source microscopic urinalysis contract agreement with Novation

Salinas Valley Memorial participates in trial of AngelMed Guardian System in high-risk heart patients

Cornerstone Healthcare Plus REIT acquires $14.75M inpatient rehabilitation facility in Dallas

Ambry Genetics acquires Illumina HiSeq 2000 Sequencing and BeadXpress Genotyping systems

Stryker Corporation announces definitive agreement to acquire Gaymar Industries

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

IMA receives five-year renewal grant from National Science Foundation

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News